Standout Papers
- Five-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Segmental Mastectomy with or without Radiation in the Treatment of Breast Cancer (1985)
- Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast Cancer (1989)
Citation Impact
Citing Papers
Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
2008
Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast Cancers of One Centimeter or Less
2002
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.
1994
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
Fibrotic Focus in Invasive Ductal Carcinoma of the Breast: A Histopathological Prognostic Parameter for Tumor Recurrence and Tumor Death within Three Years after the Initial Operation
1997
Letrozole in the extended adjuvant setting: MA.17
2007
The relationship between prognostic and predictive factors in the management of breast cancer
1998
Hypoxia Increases Breast Cancer Cell-Induced Lymphatic Endothelial Cell Migration
2008
Triple-Negative Breast Cancer
2010 Standout
Gene expression profiling predicts clinical outcome of breast cancer
2002 StandoutNature
Axillary Dissection Versus No Axillary Dissection in Elderly Patients with Breast Cancer and No Palpable Axillary Nodes: Results After 15 Years of Follow-Up
2010
Lymphangiogenesis and cancer metastasis
2002 Standout
Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.
1996
Prognostic significance of occult lymph node metastases in node-negative breast cancer
1997
Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20
2011
Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer
1999
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
1999
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
2001
The Association Between Biological Subtype and Isolated Regional Nodal Failure After Breast-Conserving Therapy
2010
Adjuvant Chemotherapy With Sequential or Concurrent Anthracycline and Docetaxel: Breast International Group 02 98 Randomized Trial
2008
Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer
1989
Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process
2005
Five Versus More Than Five Years of Tamoxifen for Lymph Node-Negative Breast Cancer: Updated Findings From the National Surgical Adjuvant Breast and Bowel Project B-14 Randomized Trial
2001
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response
2009
S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen- receptor-positive breast cancer
1998
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial
2013
A Randomized Trial Comparing Axillary Dissection to No Axillary Dissection in Older Patients With T1N0 Breast Cancer
2005
Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
2005
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer
2002 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Analyzing real-time PCR data by the comparative CT method
2008 Standout
Long-term tamoxifen citrate use and potential ocular toxicity
1998
Adjuvant therapy for breast cancer — results from the USA consensus conference
2001
Epigenetics in Cancer
2008 Standout
Lymphangiogenesis in development and human disease
2005 StandoutNature
Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer
2002 Standout
Chemoprevention of cancer
1994
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer
1997
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials
2004
Incidence of Venous Thromboembolism and Its Effect on Survival Among Patients With Common Cancers
2006
Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast Cancer
1995
Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer
2008
Tamoxifen with or without Breast Irradiation in Women 50 Years of Age or Older with Early Breast Cancer
2004
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Prevention of Venous Thromboembolism
2004 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.
1990
Lymph node micrometastases from breast carcinoma
1997
Survival impact of adjuvant tamoxifen on competing causes of mortality in breast cancer survivors, with analysis of mortality from contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic episodes.
1998
Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.
1998
The role of zoledronic acid in cancer: Clinical studies in the treatment and prevention of bone metastases
2001
Hemostatic alterations in cancer patients
1992
Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm
1991
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
2011 Standout
Breast Cancer Prognosis and Occult Lymph Node Metastases, Isolated Tumor Cells, and Micrometastases
2010
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.
1998 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Pathologic findings from the national surgical adjuvant breast project (protocol 4): Discriminants for 15-year survival
1993
Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial
2000
Prevention of Venous Thromboembolism
2008 Standout
Sox18 induces development of the lymphatic vasculature in mice
2008 StandoutNature
The Impact of Prophylactic Axillary Node Dissection on Breast Cancer Survival?A Bayesian Meta-Analysis
1999
Coronary Heart Disease Mortality and Adjuvant Tamoxifen Therapy
1997
MicroRNA expression profiles classify human cancers
2005 StandoutNatureNobel
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients
2007
Mechanisms of Bone Metastasis
2004 Standout
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
2010 Standout
Vascular Endothelial Growth Factor-C and Vascular Endothelial Growth Factor-D mRNA Expression in Breast Cancer: Association with Lymph Node Metastasis
2003
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
1998 Standout
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Molecular portraits and the family tree of cancer
2002
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6
1994
Lumpectomy versus quadrantectomy for breast conservation: a critical appraisal
1995
Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer
2006
Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer
2009
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
2003 Standout
New Perspective on Cancer of the Contralateral Breast: A Marker for Assessing Tamoxifen as a Preventive Agent
1991
Impact on Survival of Time From Definitive Surgery to Initiation of Adjuvant Chemotherapy for Early-Stage Breast Cancer
2006
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Estrogen Receptor Molecular Biology
1994
Reanalysis and Results after 12 Years of Follow-up in a Randomized Clinical Trial Comparing Total Mastectomy with Lumpectomy with or without Irradiation in the Treatment of Breast Cancer
1995
State-of the-Art Review : Prevention of Thrombosis in Gynecologic Malignancy
1998
Venous Thromboembolism and Cancer: Risks and Outcomes
2003
Breast Cancer Treatment
2019 Standout
Epirubicin Increases Long-Term Survival in Adjuvant Chemotherapy of Patients With Poor-Prognosis, Node-Positive, Early Breast Cancer: 10-Year Follow-Up Results of the French Adjuvant Study Group 05 Randomized Trial
2005
Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration.
1988
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343
2013
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
1992 Standout
Randomized, Controlled Trial of Cyclophosphamide, Methotrexate, and Fluorouracil Versus Cyclophosphamide, Doxorubicin, and Fluorouracil With and Without Tamoxifen for High-Risk, Node-Negative Breast Cancer: Treatment Results of Intergroup Protocol INT-0102
2005
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735
2010
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000
2001
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.
1994
Steroid receptors and other prognostic factors in primary breast cancer.
1988
Tamoxifen and Chemotherapy for Axillary Node-Negative, Estrogen Receptor–Negative Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-23
2001
Metabolic reprogramming and cancer progression
2020 StandoutScience
Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast Cancer
2009
Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
1997 StandoutScience
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Lumpectomy and axillary dissection for breast cancer: Surgical, pathological, and radiation considerations
1985
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Tumors: Wounds That Do Not Heal
1986 Standout
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Second Malignancies After Treatment of Early-Stage Breast Cancer: Lumpectomy and Radiation Therapy Versus Mastectomy
2000
Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee.
1991
Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
1995 StandoutScience
Randomized Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With Cyclophosphamide, Methotrexate, and Fluorouracil in Premenopausal Women With Node-Positive Breast Cancer: Update of National Cancer Institute of Canada Clinical Trials Group Trial MA5
2005
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
2002
Prevention--therapy--basic science and the resolution of the cancer problem.
1993
Works of R Poisson being referenced
Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.
1990
Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast Cancer
1989 Standout
A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors
1989
Five-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Segmental Mastectomy with or without Radiation in the Treatment of Breast Cancer
1985 Standout
Tamoxifen-induced tumor stimulation and withdrawal response.
1980
Isolation of the human anionic glutathione S-transferase cDNA and the relation of its gene expression to estrogen-receptor content in primary breast cancer.
1988
Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update
1983